Cambridge biotech startup Daktari Diagnostics Inc. has raised $5 million of a planned $10 million financing round made up of equity placement and debt, federal documents show. The new filing with the U.S. Securities and Exchange Commission doesn’t name any of the massive syndicate of 41 investors in the round, but previous backers of Daktari have included Partners Innovation Fund, Launchpad Venture Group, Hub Angels Investment Group and Boston Harbor Angels. With the new financing, Daktari has raised at least $10 million since the company was founded in 2008, the most recent being a $1.25 million debt funding in August.
